18
Participants
Start Date
October 4, 2018
Primary Completion Date
February 18, 2021
Study Completion Date
November 4, 2021
Elotuzumab
Elotuzumab according to dosing schedule outlined in treatment arms.
Lenalidomide
Lenalidomide according to dosing schedule outlined in treatment arms.
Dexamethasone
"Dexamethasone is a commercially available drug. The description, how supplied, and storage instructions for dexamethasone product are found in the prescribing information.~During the study, dexamethasone will be administered as premedication for elotuzumab as indicated in the package insert."
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
H. Lee Moffitt Cancer Center and Research Institute
OTHER